KalVista Pharmaceuticals (NASDAQ: KALV)

3d ago, source: The Motley Fool

KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors. Its product ...

KalVista Pharmaceuticals Inc KALV

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

KalVista Pharma Stock (NASDAQ:KALV), Analyst Ratings, Price Targets, Predictions

8d ago, source: Benzinga.com

There is no last upgrade for KalVista Pharma.

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

17d ago, source: Stockhouse

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista’s board of directors granted nine newly-hired employees inducement options to ...

KalVista Pharmaceuticals to Present at 23rd Annual Needham Virtual Healthcare Conference

16d ago, source: Stockhouse

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today ...

FENC Fennec Pharmaceuticals Inc.

15h ago, source: Seeking Alpha

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company’s product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention ...

KalVista Pharmaceuticals to Present at 23rd Annual Needham Virtual Healthcare Conference

16d ago, source: Yahoo Finance

CAMBRIDGE, Mass. & SALISBURY, England, April 03, 2024--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused ...

KalVista Pharmaceuticals Inc.

22d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

KALV KalVista Pharmaceuticals, Inc.

28d ago, source: Seeking Alpha

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.